Reuters Special Report: J&J's Secret Plan to Limit Payouts to Cancer Claimants
Johnson & Johnson created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the
Stay updated with breaking news from Project Plato. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Johnson & Johnson created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the
Internal company documents, depositions, and other court records reviewed by Reuters provide the most detailed account to date of how Johnson & Johnson strategized to limit compensation to tens of thousands of talc plaintiffs
If J&J succeeds, some experts argue, it could provide a blueprint for corporate America on how to circumvent jury trials involving allegations of defective products or misconduct.
By Mike Spector and Dan Levine NEW YORK (Reuters) - Johnson & Johnson created a plan last year to limit the financial bleeding from billions of dollars in jury awards to plaintiffs who alleged the company’s Baby Powder and other talc products caused deadly cancers. The healthcare and consumer-goods ...
J&J secretly launched 'Project Plato' last year to shift liability from about 38,000 pending Baby Powder talc lawsuits to a newly created subsidiary which was placed into bankruptcy